{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:31:43Z","timestamp":1780662703720,"version":"3.54.1"},"reference-count":36,"publisher":"Biomedical Research Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2022,8,18]]},"DOI":"10.2220\/biomedres.43.99","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T22:12:57Z","timestamp":1660860777000},"page":"99-106","source":"Crossref","is-referenced-by-count":6,"title":["Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma"],"prefix":"10.2220","volume":"43","author":[{"given":"Yuko","family":"SHIROUCHI","sequence":"first","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"MISHIMA","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"},{"name":"Division of Clinical Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"TAKAYAMA","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"MINOWA","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"ISHIHARA","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"TAMBA","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhito","family":"HIRANO","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"ONDA","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"TAKEUCHI","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research"},{"name":"Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"MARUYAMA","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abdelal IT, Zakaria MA, Sharaf DM and Elakad GM (2016) Levels of plasma cell-free DNA and its correlation with disease activity in rheumatoid arthritis and systemic lupus erythematosus patients. <i>Egypt Rheumatol <\/i><b>38<\/b>, 295\u2013300.","DOI":"10.1016\/j.ejr.2016.06.005"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ansari J, Yun JW, Kompelli AR, Moufarrej YE, Alexander JS, <i>et al.<\/i> (2016) The liquid biopsy in lung cancer. <i>Genes cancer <\/i><b>7<\/b>, 355\u2013367.","DOI":"10.18632\/genesandcancer.127"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, <i>et al.<\/i> (2007) Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. <i>Clin Cancer Res <\/i><b>13<\/b>, 5361\u20135367.","DOI":"10.1158\/1078-0432.CCR-06-2781"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bohers E, Viailly PJ, Becker S, Marchand V, Ruminy P, <i>et al.<\/i> (2018) Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort. <i>Blood Cancer J <\/i><b>8<\/b>, 74.","DOI":"10.1038\/s41408-018-0111-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen L, Zhang Y, Cheng Y, Zhang D, Zhu S, <i>et al.<\/i> (2018) Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis. <i>Gene <\/i><b>679<\/b>, 328\u2013334.","DOI":"10.1016\/j.gene.2018.09.029"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, <i>et al.<\/i> (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. <i>J Clin Oncol <\/i><b>32<\/b>, 3059\u20133068.","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Delfau-Larue MH, Van Der Gucht A, Dupuis J, Jais JP, Nel I, <i>et al.<\/i> (2018) Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma. <i>Blood Adv <\/i><b>2<\/b>, 807\u2013816. 3068.","DOI":"10.1182\/bloodadvances.2017015164"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Eskandari M, Manoochehrabadi S, Pashaiefar H, Zaimy MA and Ahmadvand M (2019) Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma. <i>Blood Res <\/i><b>54<\/b>, 114\u2013119.","DOI":"10.5045\/br.2019.54.2.114"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gal S, Fidler C, Lo YMD, Taylor M, Han C, <i>et al.<\/i> (2004) Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. <i>Br J Cancer <\/i><b>90<\/b>, 1211\u20131215.","DOI":"10.1038\/sj.bjc.6601609"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Galimberti S, Luminari S, Ciabatti E, Grassi S, Guerrini F, <i>et al. <\/i>(2014) Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 Trial. <i>Clin <\/i><i>Can<\/i><i>cer Res <\/i><b>20<\/b>, 6398\u20136405.","DOI":"10.1158\/1078-0432.CCR-14-0407"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Gao YJ, He YJ, Yang ZL, Shao HY, Zuo Y, <i>et al.<\/i> (2010) Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia. <i>Clin Chem Lab Med <\/i><b>48<\/b>, 1651\u20131656.","DOI":"10.1515\/CCLM.2010.311"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, <i>et al.<\/i> (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. <i>Blood <\/i><b>103<\/b>, 275\u2013282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hao TB, Shi W, Shen XJ, Qi J, Wu XH, <i>et al.<\/i> (2014) Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. <i>Br J Cancer <\/i><b>111<\/b>, 1482\u20131489.","DOI":"10.1038\/bjc.2014.470"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hohaus S, Giachelia M, Massini G, Mansueto G, Vannata B, <i>et al.<\/i> (2009) Cell-free circulating DNA in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas. <i>Ann Oncol <\/i><b>20<\/b>, 1408\u20131413.","DOI":"10.1093\/annonc\/mdp006"},{"key":"15","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, <i>et al.<\/i> (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. <i>Cancer Res <\/i><b>61<\/b>, 1659\u20131665."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Trans<\/i><i>plant <\/i><b>48<\/b>, 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kruger S, Heinemann V, Ross C, Diehl F, Nagel D, <i>et al.<\/i> (2018) Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer. <i>Ann oncol <\/i><b>29<\/b>, 2348\u20132355.","DOI":"10.1093\/annonc\/mdy417"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, <i>et al.<\/i> (2018) Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma. <i>J Clin Oncol <\/i><b>36<\/b>, 2845\u20132853.","DOI":"10.1200\/JCO.2018.78.5246"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lecomte T, Berger A, Zinzindohou\u00e9 F, Micard S, Landi B, <i>et al.<\/i> (2002) Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. <i>Int J Cancer <\/i><b>100<\/b>, 542\u2013548.","DOI":"10.1002\/ijc.10526"},{"key":"20","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ, Roz L, <i>et al.<\/i> (1977) Free DNA in the serum of cancer patients and the effect of therapy. <i>Cancer Res <\/i><b>37<\/b>, 646\u2013650."},{"key":"21","unstructured":"Mandel P and Metais P (1948) Les acides nucl\u00e9iques du plasma sanguin chez l\u2019Homme. <i>C R Seances Soc Bio Fil <\/i><b>142<\/b>, 241\u2013 243."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Moser T, Waldispuehl-Geigl J, Belic J, Weber S, Zhou Q, <i>et al.<\/i> (2020) On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer. <i>NPJ Precis Oncol <\/i><b>4<\/b>, 30.","DOI":"10.1038\/s41698-020-00134-3"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nagy \u00c1, B\u00e1tai B, Balogh A, Ill\u00e9s S, Mikala G, <i>et al.<\/i> (2020) Quantitative analysis and monitoring of EZH2 mutations us ing liquid biopsy in follicular lymphoma. <i>Genes (Basel) <\/i><b>11<\/b>, 785.","DOI":"10.3390\/genes11070785"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Patsch K, Matasci N, Soundararajan A, Diaz P, Agus DB, <i>et al.<\/i> (2019) Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA). <i>BMC Res Notes <\/i><b>12<\/b>, 275.","DOI":"10.1186\/s13104-019-4312-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, <i>et al.<\/i> (2015) Comparative study of circulating tumor DNA and computerized tomography monitoring in untreated diffuse large B-cell lymphoma. <i>Lancet Oncol <\/i><b>16<\/b>, 541\u2013549.","DOI":"10.1016\/S1470-2045(15)70106-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Rykova E, Sizikov A, Roggenbuck D, Antonenko O, Bryzgalov L, <i>et al.<\/i> (2017) Circulating DNA in rheumatoid arthritis: Pathological changes and association with clinically used serological markers. <i>Arthritis Res Ther <\/i><b>19<\/b>, 85.","DOI":"10.1186\/s13075-017-1295-z"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AFM, <i>et al.<\/i> (2016) Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. <i>Sci Transl Med <\/i><b>8<\/b>, 364ra155.","DOI":"10.1126\/scitranslmed.aai8545"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, <i>et al.<\/i> (2019) Serum level of soluble interleukin\u20102 receptor is positively correlated with metabolic tumor volume on <sup>18<\/sup>F\u2010FDG PET\/CT in newly diagnosed patients with diffuse large B\u2010cell lymphoma. <i>Cancer Med <\/i><b>8<\/b>, 953\u2013962.","DOI":"10.1002\/cam4.1973"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Siravegna G and Bardelli A (2016) Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients. <i>Mol Oncol <\/i><b>10<\/b>, 475\u2013480.","DOI":"10.1016\/j.molonc.2015.12.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Snyder MW, Kircher M, Hill AJ, Daza RM and Shendure J (2016) Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. <i>Cell <\/i><b>164<\/b>, 57\u201368.","DOI":"10.1016\/j.cell.2015.11.050"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Sozzi G, Conte D, Leon M, Ciricione R, Roz L, <i>et al.<\/i> (2003) Quantification of free circulating DNA as a diagnostic marker in lung cancer. <i>J Clin Ooncol <\/i><b>21<\/b>, 3902\u20133908.","DOI":"10.1200\/JCO.2003.02.006"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Stroun M, Lyautey J, Lederrey C, Olson-Sand A and Anker P (2001) About the possible origin and mechanism of circulating DNA: Apoptosis and active DNA release. <i>Clin Chim Acta <\/i><b>313<\/b>, 139\u2013142.","DOI":"10.1016\/S0009-8981(01)00665-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Suzuki Y, Tomita A, Nakamura F, Iriyama C, Shirahata\u2010Adachi M, <i>et al.<\/i> (2016) Peripheral blood cell\u2010free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes. <i>Cancer Sci <\/i><b>107<\/b>, 1329\u20131337.","DOI":"10.1111\/cas.12994"},{"key":"34","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <i>et al.<\/i> (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4<sup>th<\/sup> edition. IARC, Lyon, France."},{"key":"35","doi-asserted-by":"crossref","unstructured":"Tie J, Kinde I, Wang Y, Wong HL, Roebert J, <i>et al.<\/i> (2015) Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. <i>Ann Oncol <\/i><b>26<\/b>, 1715\u20131722.","DOI":"10.1093\/annonc\/mdv177"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Tug S, Helmig S, Menke J, Zahn D, Kubiak T, <i>et al.<\/i> (2014) Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients. <i>Cell Immunol <\/i><b>292<\/b>, 32\u201339.","DOI":"10.1016\/j.cellimm.2014.08.002"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/43\/4\/43_99\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:34:29Z","timestamp":1715232869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/43\/4\/43_99\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.43.99","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]}}}